Dow Jones futures rose modestly Thursday morning, along with S&P 500 futures and Nasdaq futures, with the S&P 500 eyeing a record high. Snap stock and Tesla continued to climb after big moves Wednesday, while Eli Lilly
) said it'll seek FDA approval for its Alzheimer's drug this year. Accenture
) eyed a breakout on earnings.
A bipartisan group of senators said Wednesday night they've reached the outlines of a infrastructure spending deal with the White House. An agreement could come today.
The stock market rally had a quietly bullish Wednesday, with the Nasdaq holding at record highs while leaders and growth stocks had solid sessions.
Snapchat parent Snap
) ran higher, breaking past resistance into a buy zone. Tesla
) jumped Wednesday, flashing a couple of early buy signals. Both Snap and Tesla stock continued rising in Thursday's premarket.
Accenture reported better-than-expected earnings before the open, with revenue up 20.5%, the best gain in years. The global tech and consulting firm also raised full-year guidance. ACN stock rose 4% before the open, suggesting a move above a 294.60 flat-base buy point. Accenture has been finding support at its 50-day line.
What do you think? Please email us any questions or comments.Disclaimer: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. It is for educational purposes only.For more information, see our Legal disclosures here.